Protein Structure

蛋白质结构

基本信息

项目摘要

We are studying the relationship between protein structure and function, using the technique of high-resolution X-ray diffraction. In the past year, our work has been concentrated in five distinct areas. Enzymes with Anticancer Properties We have been investigating the crystal structures of several members of the family of L-asparaginases, some of which are used clinically as drugs directed against childhood lymphoblastic leukemia. While the mechanism of anticancer activity of these enzymes is not yet clear, we have concentrated on the studies of their enzymatic properties. We have also studied these enzymes complexed with ligands such as glutamate and succinic acid, and we determined the structure of a related protein from Wolinella succinogenes. Another enzyme with potential therapeutic properties is Onconase, a cytotoxic ribonuclease isolated from frog eggs. We have been involved in reengineering this enzyme in order to make it applicable to human cancer therapy and to restore its activity in the absence of posttranslational modifications. Crystal structure of the modified enzyme has been solved. We also solved at atomic resolution the crystal structure of eosinofil-derived neurotoxin (EDN), a related enzyme now being developed as a potential anti-cancer agent. Cytokines and Cytokine Receptors Our section has been investigating the crystal structures of several cytokines and has made progress in preparing their receptor complexes. We have established that a helical cytokine, interleukin-10 (IL-10), is a domain-swapped dimer in which each compact half is composed of fragments of two identical molecules. The structure of a related cytokine encoded in the genome of Epstein-Barr virus has now been determined, providing the first glimpse of the molecular architecture of an agent used by the virus to control the host's immune system. We have solved the crystal structure of IL-19, a novel chemokine related to IL-10, and are attempting to crystallize its complexes with specific receptors. Retroviral Enzymes Enzymes encoded by retroviruses such as HIV are prime targets for designing effective drug therapies. We have been studying the structure of native and drug-resistant HIV-1 protease (PR) complexed with inhibitors, with the aim of tracing the molecular basis of the resistance phenomenon. We have also determined the structures of related enzymes from feline immunodeficiency virus (FIV) and equine infectious anemia virus (EIAV). The latter PRs are poorly inhibited by most inhibitors of HIV-1 PR, including those in clinical use, although they are capable of cleaving HIV-1-derived sequences. To study the mechanism of drug resistance, we solved the structures of HIV-1, FIV, and EIAV PRs complexed with an identical inhibitor, while the studies of an inactive mutant of FIV PR with a substrate helped in delineating the catalytic mechanism. Another retroviral enzyme under investigation in our laboratory is integrase. We have solved the structure of the catalytic domain of avian sarcoma virus integrase in the presence and absence of divalent cations to atomic resolution, and are attempting cocrystallization of complexes with different substrates. Proteins with antiviral properties We solved the crystal structure of cyanovirin-N, a protein that prevents binding of HIV to its cellular receptor. Since this is accomplished through interactions with high-mannose sugars, we also solved the structure of two such specific complexes, elucidating the mode of binding. We also obtained crystals of another protein with similar properties, scytovirin. Proteolytic enzymes Our laboratory has been working on crystal structures of a number of proteolytic enzymes. We discovered that sedolisin is a member of the subtilisin family, although it is much larger and contains a Ser-Glu-His catalytic triad. We have recently solved the structure of the proteolytic domain of and ATP-dependent E. coli protease Lon, establishing a new fold and a catalytic dyad Ser-Lys for this very interesting enzyme. We have also solved the structure of the alpha domain of Lon.
我们正在利用高分辨率x射线衍射技术研究蛋白质结构与功能之间的关系。一年来,我们的工作主要集中在五个方面。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

alexander wlodawer其他文献

alexander wlodawer的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('alexander wlodawer', 18)}}的其他基金

Chimeric ACE2 peptide ligand for diagnostic assays of SARS-CoV-2
用于 SARS-CoV-2 诊断分析的嵌合 ACE2 肽配体
  • 批准号:
    10926421
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
Protein Structure
蛋白质结构
  • 批准号:
    9343603
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
Protein Structure
蛋白质结构
  • 批准号:
    8552677
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
Protein Structure
蛋白质结构
  • 批准号:
    10014357
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
Protein Structure
蛋白质结构
  • 批准号:
    8763085
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
Chimeric ACE2 peptide ligand for diagnostic assays of SARS-CoV-2
用于 SARS-CoV-2 诊断分析的嵌合 ACE2 肽配体
  • 批准号:
    10262576
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
Protein Structure
蛋白质结构
  • 批准号:
    10926006
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
Protein Structure
蛋白质结构
  • 批准号:
    7965279
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
Chimeric ACE2 peptide ligand for diagnostic assays of SARS-CoV-2
用于 SARS-CoV-2 诊断分析的嵌合 ACE2 肽配体
  • 批准号:
    10702777
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
Protein Structure
蛋白质结构
  • 批准号:
    8157286
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:

相似海外基金

CHEMICAL SCREENING AND OPTIMIZATION FACILITY - PROTEIN EXPRESSION AND/OR X-RAY CRYSTALLOGRAPHY
化学筛选和优化设施 - 蛋白质表达和/或 X 射线晶体学
  • 批准号:
    10942884
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Taking Snapshots of Enzymatic Reactions Using X-ray Crystallography and Spectroscopy
使用 X 射线晶体学和光谱学拍摄酶反应快照
  • 批准号:
    10623717
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
EAGER: JOINT CRYO NEUTRON/X-RAY CRYSTALLOGRAPHY OF RNA AND RNA-PROTEIN INTERACTIONS
EAGER:RNA 和 RNA-蛋白质相互作用的联合冷冻中子/X 射线晶体学
  • 批准号:
    2224897
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
    Standard Grant
Protein structure-based enhancement of enzyme performance for food and bioproduct applications using X-ray crystallography, protein modification and metabolic engineering methods
使用 X 射线晶体学、蛋白质修饰和代谢工程方法,基于蛋白质结构增强食品和生物产品应用中的酶性能
  • 批准号:
    RGPIN-2016-06209
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
    Discovery Grants Program - Individual
Time-Resolved X-ray Crystallography of Dynamics in Cysteine-Dependent Enzymes
半胱氨酸依赖性酶动力学的时间分辨 X 射线晶体学
  • 批准号:
    10684770
  • 财政年份:
    2020
  • 资助金额:
    --
  • 项目类别:
Time-Resolved X-ray Crystallography of Dynamics in Cysteine-Dependent Enzymes
半胱氨酸依赖性酶动力学的时间分辨 X 射线晶体学
  • 批准号:
    10259757
  • 财政年份:
    2020
  • 资助金额:
    --
  • 项目类别:
Elucidating the Hidden Steps of Replicative DNA Synthesis by Time-Resolved X-ray Crystallography
通过时间分辨 X 射线晶体学阐明复制 DNA 合成的隐藏步骤
  • 批准号:
    2001434
  • 财政年份:
    2020
  • 资助金额:
    --
  • 项目类别:
    Standard Grant
Time-Resolved X-ray Crystallography of Dynamics in Cysteine-Dependent Enzymes
半胱氨酸依赖性酶动力学的时间分辨 X 射线晶体学
  • 批准号:
    10099548
  • 财政年份:
    2020
  • 资助金额:
    --
  • 项目类别:
Optimizing protein expression for X-ray crystallography studies and medicinal chemistry
优化 X 射线晶体学研究和药物化学的蛋白质表达
  • 批准号:
    552236-2020
  • 财政年份:
    2020
  • 资助金额:
    --
  • 项目类别:
    University Undergraduate Student Research Awards
Protein structure-based enhancement of enzyme performance for food and bioproduct applications using X-ray crystallography, protein modification and metabolic engineering methods
使用 X 射线晶体学、蛋白质修饰和代谢工程方法,基于蛋白质结构增强食品和生物产品应用中的酶性能
  • 批准号:
    RGPIN-2016-06209
  • 财政年份:
    2020
  • 资助金额:
    --
  • 项目类别:
    Discovery Grants Program - Individual
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了